An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Por:
Panisello, C, Bueno, C, Castilla, C, Aschero MR, Carcaboso AM, de Alava, E and Menendez, P
Publicada:
1 may 2023
Resumen:
Filiaciones:
Panisello, C:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
Bueno, C:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
Castilla, C:
Virgen Rocio Univ Hosp, Inst Biomed Sevilla IBiS, Seville, Spain
Aschero MR:
Inst Recerca Sant Joan de Deu, Barcelona, Spain
Carcaboso AM:
Inst Recerca Sant Joan de Deu, Barcelona, Spain
de Alava, E:
Virgen Rocio Univ Hosp, Inst Biomed Sevilla IBiS, Seville, Spain
Menendez, P:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
|